MBL77 FUNDAMENTALS EXPLAINED

Not all sufferers with CLL have to have therapy. Inspite of all current developments, the iwCLL nevertheless endorses watchful observation for sufferers with asymptomatic disease.86 This suggestion is based on at least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR